Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Cancer Science|July 26, 2006
Therapeutic potential of RNA interference against cancerFumitaka Takeshita, Takahiro Ochiya
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 3, 2007
[Application of atelocollagen-mediated siRNA delivery for RNAi therapies]Kimi Honma, Fumitaka Takeshita, Takahiro Ochiya
Japanese Journal of Clinical Oncology|April 18, 2013
RNAi therapeutics and applications of microRNAs in cancer treatmentKeita Uchino, Takahiro Ochiya, Fumitaka Takeshita
Idrugs : the Investigational Drugs Journal|April 2, 2008
RNAi-based drug discovery and its application to therapeuticsNaomi Hokaiwado, Fumitaka Takeshita, Agnieszka Banas, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Atelocollagen-mediated drug discovery technologyTakahiro Ochiya, Kimi Honma, Fumitaka Takeshita, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
RNAi Therapeutic Platforms for Lung DiseasesYu Fujita, Fumitaka Takeshita, Kazuyoshi Kuwano, et al.
Proteomics|January 22, 2013
The therapeutic potential of mesenchymal stem cell-derived extracellular vesiclesTakeshi Katsuda, Nobuyoshi Kosaka, Fumitaka Takeshita, et al.
Biomed Research International|October 9, 2014
The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer researchYu Fujita, Kazuyoshi Kuwano, Takahiro Ochiya, et al.
Cancer Letters|April 23, 2003
Mechanistic approach of contrasting modifying effects of caffeine on carcinogenesis in the rat colon and mammary gland induced with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridineFumitaka Takeshita, Kumiko Ogawa, Makoto Asamoto, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 16, 2012
In vivo imaging of oligonucleotide deliveryFumitaka Takeshita, Ryou-U Takahashi, Jun Onodera, et al.
Pageof 9